
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
2
Investigators Link Maternal Distress With Neurodevelopmental Delay Among Children
3
Pharmacists Reimagine the Future of Pharmacy
4
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
5




















































































































































